Literature DB >> 12931553

Analysis of CD10+ hairy cell leukemia.

Tammy M Jasionowski1, Leah Hartung, Jay H Greenwood, Sherrie L Perkins, David W Bahler.   

Abstract

Hairy cell leukemia (HCL) has been reported to sometimes express CD10. However, the reported frequencies have been quite variable and the significance of CD10 expression has not been addressed. Cases of HCL submitted to our flow cytometry service during a 2-year period were evaluated for CD10 expression. Information regarding demographics, clinical manifestations, tissue morphologic features, and response to treatment was reviewed. Of the 97 HCL cases identified, 10 expressed CD10. The level of CD10 staining was typically well above control levels and also could be detected easily by immunohistochemical analysis. All cases analyzed were negative for bcl-6. Our study suggests that approximately 10% of otherwise typical cases of HCL show aberrant CD10 expression. CD10+ HCL cases seem to be morphologically and clinically similar to CD10-HCL cases. Appreciating that HCL can express CD10 may be especially important when evaluating specimens with suboptimal morphologic features and/or limited immunophenotyping panels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931553     DOI: 10.1309/QVJD-31TE-G9UJ-18BQ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Immunophenotypic aberrancy of a case of hairy cell leukemia.

Authors:  Abhishek Purohit; S Venkatesan; Mukul Aggarwal; Jasdeep Singh; Rahul Sharma; Manoranjan Mahapatra; Hara P Pati; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-20       Impact factor: 0.900

3.  Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.

Authors:  Haipeng Shao; Katherine R Calvo; Marlene Grönborg; Prashant R Tembhare; Robert J Kreitman; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Leuk Res       Date:  2013-01-22       Impact factor: 3.156

4.  Haematological profile of 21 patients with hairy cell leukaemia in a tertiary care centre of north India.

Authors:  Arvind Kumar Gupta; Man Updesh Singh Sachdeva; Jasmina Ahluwalia; Reena Das; Shano Naseem; Prashant Sharma; Narender Kumar; Pankaj Malhotra; Neelam Varma; Subhash Varma
Journal:  Indian J Med Res       Date:  2015-10       Impact factor: 2.375

5.  Vasculitides associated with haematological malignancies: a case-based review.

Authors:  Shuchi Gulati; Nirav P Patel; Sharon L Swierczynski
Journal:  BMJ Case Rep       Date:  2012-10-19

6.  Hairy cell leukemia: A decade long experience of North Indian Hematology Center.

Authors:  Venkatesan Somasundaram; Abhishek Purohit; Mukul Aggarwal; Prabhu Manivannan; Pravas Mishra; Tulika Seth; Seema Tyagi; Manoranjan Mahapatra; Hara P Pati; Renu Saxena
Journal:  Indian J Med Paediatr Oncol       Date:  2014-10

7.  New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.

Authors:  Elsa Maitre; Philippe Bertrand; Catherine Maingonnat; Pierre-Julien Viailly; Margaux Wiber; Dina Naguib; Véronique Salaün; Edouard Cornet; Gandhi Damaj; Brigitte Sola; Fabrice Jardin; Xavier Troussard
Journal:  Oncotarget       Date:  2018-06-22

Review 8.  Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma.

Authors:  Rami Abdulbaki; Parastou Tizro; Victor E Nava; Maria Gomes da Silva; João L Ascensão
Journal:  Curr Oncol       Date:  2021-11-18       Impact factor: 3.677

9.  Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.

Authors:  Elsa Maitre; Edouard Cornet; Véronique Salaün; Pauline Kerneves; Stéphane Chèze; Yohan Repesse; Gandhi Damaj; Xavier Troussard
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

Review 10.  CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.

Authors:  John J Schmieg; Jeannie M Muir; Nadine S Aguilera; Aaron Auerbach
Journal:  Curr Oncol       Date:  2021-12-04       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.